Gland Pharma Limited has informed the Exchange about Schedule of meet
GLAND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Gland Pharma has disclosed a schedule of two investor meetings on June 4, 2026 - a group meeting arranged by Bank of America (BofA) and a one-on-one meeting with Emkay Global. This is a routine regulatory disclosure under SEBI LODR Regulation 30, informing the market about planned management interactions with institutional investors and analysts. The company has clarified that the schedule is subject to change due to exigencies. No new financial information, guidance, or material developments were disclosed in this filing.
This is a standard transparency disclosure with no direct impact on the stock. It indicates active investor relations but does not signal any specific positive or negative corporate development.